Lack of Insurance Keeps Many Americans From Best Cancer Meds
Key Takeaways
Drugs called immune checkpoint inhibitors have greatly improved the survival of many cancer patientsThe drugs are expensive, however, and new research suggests many uninsured people just can't access themMore must be done to create policies that help every cancer patient access these meds
But the drugs, called immune checkpoint inhibitors (ICIs), are so expensive that some uninsured Americans can't access them, a new report finds.
New policies are needed "to improve health insurance coverage options and to make new treatments more affordable," the
The study was led by ACS researcher Dr.
ICIs include such blockbuster cancer medications as pembrolizumab (Keytruda), ipilimumab (Yervoy), nivolumab (Opdivo) and atezolizumab (Tecentriq).
According to the
Immune checkpoints are natural mechanisms meant to keep immune reactions from running amok.
However, disengaging these checkpoints in the presence of a cancer cell is crucial to allowing immunotherapies to work.
A drug that inhibits checkpoint proteins "prevents the 'off' signal from being sent, allowing the T cells to kill cancer cells," the NCI explained.
First approved in 2011, ICI drugs have revolutionized cancer care and they are now used against a wide range of cancer types.
But they remain expensive.
In the new study, Zhao's group tracked outcomes for patients ages 18 to 64 who were diagnosed with advanced (stage 4) cancers.
An ICI drug had already been FDA-approved to fight these cancers, which included melanoma and cancers of the breast, kidney and lungs.
Having good health insurance appeared key to whether or not patients could reap the full benefit of these drugs, Zhao's group found.
For example, among patients diagnosed with advanced melanomas, those who had private health insurance saw rates of 2-year survival rise from 29.6% before their ICI drug was approved to 41.8% after approval.
But uninsured patients with the same disease saw less improvement: 17.5% saw 2-year survival prior to ICI approval, and 24.4% saw it afterwards.
Similar results by insurance status were seen among patients battling advanced kidney or lung cancers, Zhao's team added.
All of this points to an inability by some patients to find coverage for ICI medicines that could help them survive, the researchers concluded.
Because these findings were presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.
More information
Find out more about immune checkpoint inhibitors at the
SOURCE:
What This Means For You
Drugs called immune checkpoint inhibitors are extending the lives of people with cancer -- if they can afford them.


Patent Application Titled “Hardware-Accelerated Homomorphic Encryption In Marketplace Platforms” Published Online (USPTO 20240160771): Patent Application
Federal Judge tosses Florida Gov. DeSantis lawsuit on children's health insurance
Advisor News
- Survey: Most Americans still feel prosperous despite economic worries
- SEC settlement would require Tai Lopez, two others, to pay $6.8 million
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
More Annuity NewsHealth/Employee Benefits News
- EXPLORING INSULIN COST-SHARING CAPS FOR PATIENTS WITH PRIVATE COVERAGE
- THE AMERICAN DIABETES ASSOCIATION FIGHTS TO MAINTAIN ACCESS TO HEALTH INSURANCE
- Grand jury accuses veteran of making false disability claims that defrauded VA
- States push short-term insurance as healthcare costs climb
- Study Findings on Managed Care Are Outlined in Reports from Massachusetts General Hospital (A RUC Rescue of Primary Care?): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- FORMER PRINCE GEORGE'S COUNTY INSURANCE AGENT SENTENCED FOR FELONY INSURANCE THEFT SCHEME
- AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
- AM Best Takes Various Credit Rating Actions on Certain Subsidiaries of Auto-Owners Insurance Group
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- AM Best Downgrades Credit Ratings of CICA Life Insurance Company of America
More Life Insurance News